After a period of significant internal challenges, UnitedHealth appears to be staging a powerful recovery.
The company's third-quarter results showed a 12 percent increase in revenue, reaching $113.2 billion, and adjusted earnings per share of $2.92, surpassing the consensus analyst estimate of $2.87.
Investor sentiment received a substantial boost from the company's decision to raise its annual outlook.
This performance suggests a potential turning point following a year marked by executive changes and withdrawn guidance.
Author's summary: UnitedHealth reports robust quarterly figures.